1、 唐国文.甲状腺癌术后患者生活质量评估[J]. 广州医药,2014,1(45):42-44. 唐国文.甲状腺癌术后患者生活质量评估[J]. 广州医药,2014,1(45):42-44.
2、 SO YK, SEO MY, SON YL. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications[J]. Surgery, 2012,151(2):192-198. SO YK, SEO MY, SON YL. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications[J]. Surgery, 2012,151(2):192-198.
3、 CALISKAN M, PARK JH, JEONG JS, et al. Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma[J]. Endocr J, 2012,59(4):305-311. CALISKAN M, PARK JH, JEONG JS, et al. Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma[J]. Endocr J, 2012,59(4):305-311.
4、 HYUN SM, SONG HY, KIM SY, et al. Impact of combined prophylactic unilateral central neck dissection and hemithyroidectomy in patients with papillarythyroid microcarcinoma[J]. Ann Surg Oncol, 2012,19(2): 591-6. HYUN SM, SONG HY, KIM SY, et al. Impact of combined prophylactic unilateral central neck dissection and hemithyroidectomy in patients with papillarythyroid microcarcinoma[J]. Ann Surg Oncol, 2012,19(2): 591-6.
5、 LIM YC, CHOI EC, YOON YH, et al. Central lymph node metastases in unilateral papillary thyroid microcarcinoma[J]. Br J Surg, 2009,96(3):253-257. LIM YC, CHOI EC, YOON YH, et al. Central lymph node metastases in unilateral papillary thyroid microcarcinoma[J]. Br J Surg, 2009,96(3):253-257.
6、 LONDERO SC, KROGDAHL A, BASTHOLT L, et al. Papillarythyroid microcarcinoma in Denmark 1996-2008: A national study of epidemiology and clinical significance[J]. Thyroid, 2013, 58(4):301-309. LONDERO SC, KROGDAHL A, BASTHOLT L, et al. Papillarythyroid microcarcinoma in Denmark 1996-2008: A national study of epidemiology and clinical significance[J]. Thyroid, 2013, 58(4):301-309.
7、 YU XM, LLOYD R, CHEN H. Current treatmentof papillarythyroid microcarcinoma[J]. Adv Surg, 2012, 46:191-203. YU XM, LLOYD R, CHEN H. Current treatmentof papillarythyroid microcarcinoma[J]. Adv Surg, 2012, 46:191-203.
8、 SO YK, SON YI, HONG SD, et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections[J]. Surgery, 2010,148(3): 526-531. SO YK, SON YI, HONG SD, et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections[J]. Surgery, 2010,148(3): 526-531.
9、 LOMBARDI CP, BELLANTONE R, DE CREA C, et al. Papillarythyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area[J]. World J Surg, 2010,34 (6): 1214-1221. LOMBARDI CP, BELLANTONE R, DE CREA C, et al. Papillarythyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area[J]. World J Surg, 2010,34 (6): 1214-1221.
10、 巫泓生,张帅,古维立.有关甲状腺癌肿瘤标志物的探讨[J]. 实用医学, 2009, 25(22):3900-3902. 巫泓生,张帅,古维立.有关甲状腺癌肿瘤标志物的探讨[J]. 实用医学, 2009, 25(22):3900-3902.
11、 沈樑,张帅,古维立,等.甲状腺肿瘤血管内皮生长因子,环氧合酶-2表达和临床意义[J]. 现代医院,2014,4(40):11-14. 沈樑,张帅,古维立,等.甲状腺肿瘤血管内皮生长因子,环氧合酶-2表达和临床意义[J]. 现代医院,2014,4(40):11-14.
12、 VIRK RK, VAN DYKE AL, FINKELSTEIN A, et al. BRAF(V600E) mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation[J]. Modern pathology, 2012,27(2):161-165. VIRK RK, VAN DYKE AL, FINKELSTEIN A, et al. BRAF(V600E) mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation[J]. Modern pathology, 2012,27(2):161-165.
